Polaris Market Research estimates the global vagus nerve stimulation (VNS) market will grow from $8.59 billion in 2021 to $21.3 billion in 2030, a 10.6% CAGR over the forecast period. Additionally, ...

Electrocore ( (ECOR) ) has released its Q3 earnings. Here is a breakdown of the information Electrocore presented to its investors.

Pulsetto has launched what is being billed as “the ultimate guide” to their vagus nerve stimulation device and the benefits ...

Research shows stimulating the vagus nerve can relieve a host of health problems and create feelings of calm. Could a new ...

Research shows stimulating the vagus nerve can relieve a host of health problems and create feelings of calm. Could a new ...

ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness ...

Vagus nerve stimulation (VNS) is a neuromodulation therapy, which means it’s a treatment that changes the patterns of activity of your nerves. Vagus nerve stimulation can treat epilepsy, seizures, and ...

With the presidential election season behind us, a major source of uncertainty has been lifted, creating an ideal opportunity for investors to ...

Researchers found that exercise promotes neuron growth through both biochemical signals (myokines) and physical stretching.

The grant will aid in carrying out laparoscopic surgical electrode implantation approaches and studies in a porcine model.

But a Lake Worth scientist and inventor has a product on the market that he says helps athletes deal with and prevent ...

The development team at Pulsetto have published the results of their research into whether vagus nerve stimulation (VNS) ...